Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACM-I Questionnaire in Chronic Migraine with BOTOX
NCT01833130Phase 4Completed
- Sponsor
- Allergan
- Start
- Apr 2013
- Primary completion
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA in chronic migraine, sponsored by Allergan. Started Apr 2013; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT01833130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833130.